CLEARSIGHT RT LLC

Clearsight RT LLC specializes in single-use radiation therapy bolus devices. These products are specifically designed to improve dose distribution during external beam radiotherapy by conforming to the patient’s contours, which helps enhance precision for treating skin and subcutaneous tissues. Bolus devices are used to ensure the radiation dose reaches the intended treatment area effectively.

Clearsight RT LLC is based in the United States, which means its devices fall under the jurisdiction of the US Food and Drug Administration (FDA). As a US-based manufacturer, the company’s products must comply with FDA regulations, including registration and listing requirements. The FDA’s Unique Device Identifier (UDI) database includes Clearsight RT LLC’s devices, reflecting their regulatory status under US medical device laws.

Clearsight RT LLC’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is a standardized way for manufacturers to identify their medical devices, ensuring traceability and transparency in regulatory oversight. Listing in this database is a requirement for Class I devices in the US, helping healthcare providers and regulators verify the identity and compliance status of the products.

Clearsight RT LLC’s devices are classified as Class I medical devices under FDA regulations. Class I devices are generally considered to pose the lowest risk and often involve minimal direct regulation beyond good manufacturing practices. However, even Class I devices must meet specific requirements, such as proper labeling and adherence to safety standards, particularly when used in specialized applications like radiation therapy. The classification ensures that these bolus devices are subject to appropriate oversight while balancing regulatory burden with the nature of their use.